You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Zhou Jiwang looked at the old man in front of him. He was in a daze. He was a young man in his twenties. Although he was younger than the old man in front of him, he didn't know how old he was, but he was called by the other side. He was still not used to it. He wanted to answer the old man's question, opened his mouth, and his throat stung. He couldn't say a word. He wanted to struggle to sit up, but he couldn't use any strength. He simply couldn't feel his body, only
A groundbreaking book that describes a distinctively Chinese avant-gardism and a modernity that unifies art, politics, and social life. To the extent that Chinese contemporary art has become a global phenomenon, it is largely through the groundbreaking exhibitions curated by Gao Minglu: "China/Avant-Garde" (Beijing, 1989), "Inside Out: New Chinese Art" (Asia Society, New York, 1998), and "The Wall: Reshaping Contemporary Chinese Art" (Albright-Knox Art Gallery, 2005) among them. As the first Chinese writer to articulate a distinctively Chinese avant-gardism and modernity—one not defined by Western chronology or formalism—Gao Minglu is largely responsible for the visibility of Chinese art...
This volume presents the proceedings of Symposium I "Stratigraphy" of the 30th International Geological Congress at Beijing. The proceedings aim to present a view of contemporary geology and should be of interest to researchers in the geological sciences.
Invaluable resource for anyone who wants to understand contemporary Chinese art, one of the most fascinating art scenes of the late 20th and early 21st centuries.
This standard is applicable to the design of foundation of industrial buildings and civil buildings.
Dr. Koguchi receives funding from Tesaro, a GSK company, Bristol-Myers Squibb, and Shimadzu Corporation.. Dr. Vujanovic is a co-inventor of a methodology licensed to INmune Bio, Inc. where a selective inhibitor of soluble TNF can be used to prevent or treat malignancies. Dr. Hansen is the recipient of a private grant from Eurostars Eureka. The other Topic Editors declare no competing interests.
Topic Editor, Prof. Heinrich Audebert, received funding from institutional funding by Roche Diagnostics International Ltd. and the Berlin Future Funds. The other Topic Editors declare no competing interests with regard to the Research Topic subject.